Latest Mapatumumab Stories
ROCHESTER, N.Y., Dec. 9, 2014 /PRNewswire/ -- Vaccinex, Inc.
CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- Boston Biomedical, a company focused on the research and development of novel cancer therapeutics targeting cancer stem cells (CSC), today provided
New results from a trial of an antibody that helps the immune system to recognize and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.
- A political dynamiter.